Diagnosis of a genetic cause in hundreds of people with motor neuron disease could be missed due to “arbitrary age limits and rules” on genetic testing, new study shows
Based on the findings of a new study published in Brain, researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London are calling for a complete rethink of the national guidelines surrounding who can access genetic testing for amyotrophic lateral sclerosis (ALS), also called motor neuron disease.
By NIHR Maudsley BRC at 27 Sep 2022
